Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol

Overview of attention for article published in BMC Cancer, July 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 141 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 193 followers.

Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial… https://t.co/lrJniVtv17

Reply Repost Favourite